Tumor necrosis factor-α production from mononuclear cells in nephrotic syndrome

Tumor necrosis factor-α (TNF-α) levels in supernatant fluid from cultured peripheral blood mononuclear cells (PBMC) were measured by ELISA in 54 children with active non-inherited forms of primary nephrotic syndrome (PNS), 10 nephrotics in remission, and 10 healthy controls. Children with active PNS included 21 patients with steroid-sensitive (SS) minimal change nephrotic syndrome (MCNS), 5 patients with steroid–resistant (SR) MCNS, 11 with SR focal segmental glomerulosclerosis (FSGS), 6 patients with SS diffuse mesangial proliferation (DMP), 5 patients with SR DMP, and 6 patients with mesangiocapillary glomerulonephritis (MCGN). Patients with active PNS had elevated TNF-α production compared with controls. Remission was associated with normalization of TNF-α production. There was a positive correlation between TNF-α production and the degree of proteinuria (r=0.34, P=0.013), mesangial hypercellularity (r=0.42, P=0.028), and glomerulosclerosis (r=0.46, P=0.001). By using ROC curve, TNF-α production greater or equal to a cut-off point of 50 pg/ml could be used to predict resistance to steroid therapy (predictability 93.2%). By discriminate analysis, TNF-α production could be used to discriminate between patients with SR MCNS, SR FSGS, and SR DMP (predictability 100%). In conclusion, TNF-α from cultured PBMC might be involved in the pathogenesis of proteinuria as well as the pathological changes that occur in non-inherited forms of PNS. TNF-α levels in PBMC culture could be used to predict the pathological type of PNS and the response of these patients to steroid therapy.